Gsa Capital Partners LLP Annexon, Inc. Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
A detailed history of Gsa Capital Partners LLP transactions in Annexon, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 34,581 shares of ANNX stock, worth $228,580. This represents 0.02% of its overall portfolio holdings.
Number of Shares
34,581
Previous 31,226
10.74%
Holding current value
$228,580
Previous $153,000
33.99%
% of portfolio
0.02%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ANNX
# of Institutions
158Shares Held
102MCall Options Held
3.61MPut Options Held
1.08M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$55.8 Million8.47% of portfolio
-
Satter Management Co., L.P.7.41MShares$49 Million76.44% of portfolio
-
Bvf Inc San Francisco, CA7MShares$46.3 Million1.05% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$43.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$42.5 Million2.05% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $315M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...